Literature DB >> 23867582

Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis.

Shugo Suzuki1, Pornsiri Pitchakarn, Kumiko Ogawa, Aya Naiki-Ito, Teera Chewonarin, Wanisa Punfa, Makoto Asamoto, Tomoyuki Shirai, Satoru Takahashi.   

Abstract

Understanding of mechanisms of cancer progression is very important for reduction of cancer mortality. Of six rat hepatocellular carcinoma (HCC) cell lines, differing in their metastatic potential to the lung after inoculation into the tail vein of nude mice, the most metastatic featured particular overexpression of glutathione peroxidase 2 (GPX2). Therefore, we analyzed the influence of interference in highly metastatic L2 cells by siRNA transfection. Gpx2 siRNA significantly inhibited cell proliferation at 24 and 48h time points with induction of apoptosis but not cell cycle arrest. High expression of mutated p53 was detected in all HCC cell lines, with reduction in Gpx2 siRNA-transfected cells. Migration and invasion in vitro were also suppressed as compared to control siRNA-transfected cells and secretion of matrix metalloproteinase 9 was reduced. In vivo, the numbers and areas of metastatic nodules per area in the lungs were significantly reduced in the mice inoculated with Gpx2 siRNA-transfected cells as compared to control siRNA-transfected cells. In conclusion, expression of GPX2 is associated with cancer metastasis from rat HCCs both in vitro and in vivo. Together with immunohistochemical findings of elevated expression in rat and also human liver lesions, the results point to important roles in hepatocarcinogenesis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer progression; Carcinogenesis; Glutathione peroxidase 2; Hepatocellular carcinoma; Metastasis

Mesh:

Substances:

Year:  2013        PMID: 23867582     DOI: 10.1016/j.tox.2013.07.005

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  11 in total

Review 1.  The beginning of GPX2 and 30 years later.

Authors:  R Steven Esworthy; James H Doroshow; Fong-Fong Chu
Journal:  Free Radic Biol Med       Date:  2022-07-05       Impact factor: 8.101

Review 2.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

Review 3.  Selenoproteins and Metastasis.

Authors:  Michael P Marciel; Peter R Hoffmann
Journal:  Adv Cancer Res       Date:  2017-09-01       Impact factor: 6.242

4.  GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.

Authors:  Taku Naiki; Aya Naiki-Ito; Keitaro Iida; Toshiki Etani; Hiroyuki Kato; Shugo Suzuki; Yoriko Yamashita; Noriyasu Kawai; Takahiro Yasui; Satoru Takahashi
Journal:  Oncotarget       Date:  2018-03-23

Review 5.  Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?

Authors:  Marina Serra; Amedeo Columbano; Ummi Ammarah; Massimiliano Mazzone; Alessio Menga
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

6.  Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.

Authors:  Aya Naiki-Ito; Taku Naiki; Hiroyuki Kato; Keitaro Iida; Toshiki Etani; Yuko Nagayasu; Shugo Suzuki; Yoriko Yamashita; Shingo Inaguma; Masaya Onishi; Yasuhito Tanaka; Takahiro Yasui; Satoru Takahashi
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

7.  A pan-cancer study of selenoprotein genes as promising targets for cancer therapy.

Authors:  Wentao Wu; Daning Li; Xiaojie Feng; Fanfan Zhao; Chengzhuo Li; Shuai Zheng; Jun Lyu
Journal:  BMC Med Genomics       Date:  2021-03-11       Impact factor: 3.063

8.  The Effect of GPX2 on the Prognosis of Lung Adenocarcinoma Diagnosis and Proliferation, Migration, and Epithelial Mesenchymal Transition.

Authors:  Yu-Peng Li; Rui Lin; Ming-Zhu Chang; Yi-Jiu Ai; Si-Ping Ye; Hui-Ming Han; Yao-Yue Zhang; Han Mou; Run-Hong Mu; Xiao Guo
Journal:  J Oncol       Date:  2022-07-18       Impact factor: 4.501

9.  Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.

Authors:  Zhijin Lei; Dongping Tian; Chong Zhang; Shukun Zhao; Min Su
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

10.  GPX8 promotes migration and invasion by regulating epithelial characteristics in non-small cell lung cancer.

Authors:  Jun Zhang; Yun Liu; Yan Guo; Qiang Zhao
Journal:  Thorac Cancer       Date:  2020-09-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.